Publication:
Synthesis and Antitumor Activity Evaluation of Compounds Based on Toluquinol.

dc.contributor.authorCheng-Sanchez, Ivan
dc.contributor.authorTorres-Vargas, Jose A
dc.contributor.authorMartinez-Poveda, Beatriz
dc.contributor.authorGuerrero-Vásquez, Guillermo A
dc.contributor.authorMedina, Miguel Angel
dc.contributor.authorSarabia, Francisco
dc.contributor.authorQuesada, Ana R
dc.date.accessioned2023-01-25T13:40:08Z
dc.date.available2023-01-25T13:40:08Z
dc.date.issued2019-08-23
dc.description.abstractEncouraged by the promising antitumoral, antiangiogenic, and antilymphangiogenic properties of toluquinol, a set of analogues of this natural product of marine origin was synthesized to explore and evaluate the effects of structural modifications on their cytotoxic activity. We decided to investigate the effects of the substitution of the methyl group by other groups, the introduction of a second substituent, the relative position of the substituents, and the oxidation state. A set of analogues of 2-substituted, 2,3-disubstituted, and 2,6-disubstituted derived from hydroquinone were synthesized. The results revealed that the cytotoxic activity of this family of compounds could rely on the hydroquinone/benzoquinone part of the molecule, whereas the substituents might modulate the interaction of the molecule with their targets, changing either its activity or its selectivity. The methyl group is relevant for the cytotoxicity of toluquinol, since its replacement by other groups resulted in a significant loss of activity, and in general the introduction of a second substituent, preferentially in the para position with respect to the methyl group, was well tolerated. These findings provide guidance for the design of new toluquinol analogues with potentially better pharmacological properties.
dc.description.versionSi
dc.identifier.citationCheng-Sánchez I, Torres-Vargas JA, Martínez-Poveda B, Guerrero-Vásquez GA, Medina MÁ, Sarabia F, et al. Synthesis and Antitumor Activity Evaluation of Compounds Based on Toluquinol. Mar Drugs. 2019 Aug 23;17(9):492
dc.identifier.doi10.3390/md17090492
dc.identifier.essn1660-3397
dc.identifier.pmcPMC6780176
dc.identifier.pmid31450731
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780176/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/1660-3397/17/9/492/pdf?version=1566546735
dc.identifier.urihttp://hdl.handle.net/10668/14443
dc.issue.number9
dc.journal.titleMarine drugs
dc.journal.titleabbreviationMar Drugs
dc.language.isoen
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.page.number16
dc.provenanceRealizada curación de contenido 13/09/2024
dc.publisherMDPI
dc.pubmedtypeJournal Article
dc.relation.publisherversionhttps://www.mdpi.com/1660-3397/17/9/492
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectantitumor
dc.subjectmarine hydroquinone
dc.subjectnatural compound analogues
dc.subjectthymoquinone
dc.subjecttoluquinol
dc.subject.decsAntineoplásicos
dc.subject.decsDiseño de fármacos
dc.subject.decsEnsayos de selección de medicamentos antitumorales
dc.subject.decsEstructura molecular
dc.subject.decsHidroquinonas
dc.subject.decsHumanos
dc.subject.decsLínea celular tumoral
dc.subject.decsRelación estructura-actividad
dc.subject.meshAntineoplastic agents
dc.subject.meshCell Line, tumor
dc.subject.meshDrug Design
dc.subject.meshDrug screening assays, antitumor
dc.subject.meshHumans
dc.subject.meshHydroquinones
dc.subject.meshMolecular structure
dc.subject.meshStructure-activity relationship
dc.titleSynthesis and Antitumor Activity Evaluation of Compounds Based on Toluquinol.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number17
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC6780176.pdf
Size:
7.04 MB
Format:
Adobe Portable Document Format